6191 Cornerstone Court, East
Suite 114
San Diego, CA 92121
United States
858 923 4422
https://www.aximbiotech.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 6
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. John W. Huemoeller II | President, CEO & Director | 420k | N/A | 1955 |
Mr. Robert T. Malasek | CFO & Secretary | 90k | N/A | 1968 |
Ms. Catalina Valencia J.D. | Co-Founder & CEO of Sapphire Biotech, Inc. | 187,5k | N/A | 1949 |
Mr. Kurt Phinney | Chief Operating Officer | N/A | N/A | 1973 |
Dr. Sergei A. Svarovsky M.B.A., Ph.D. | Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc. | N/A | N/A | N/A |
Dr. Douglas Lake Ph.D. | Chief Clinical Officer of Sapphire Biotech, Inc. | N/A | N/A | N/A |
Dr. Alim Seit-Nebi Ph.D. | CTO & Co-Founder of Sapphire Biotech, Inc. | N/A | N/A | N/A |
Mr. Jeffrey A. Busby | Senior Vice President of Business Development | N/A | N/A | N/A |
Dr. Joseph Tauber M.D. | Chief Medical Officer & Chairman of the Medical Advisory Board | N/A | N/A | 1957 |
Dr. Maria J. Gonzalez Moa Ph.D. | Vice President of Product Development - Sapphire Biotech, Inc. | N/A | N/A | N/A |
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
El ISS Governance QualityScore de AXIM Biotechnologies, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.